Press release from GlobeNewswire (a Nasdaq OMX company)
TearLab to Participate in the 2013 Stephens Fall Investment Conference
Wednesday, November 06, 2013
TearLab to Participate in the 2013 Stephens Fall Investment Conference13:45 EST Wednesday, November 06, 2013
SAN DIEGO, Nov. 6, 2013 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the Stephens Fall Investment Conference on Wednesday, November 13 at 11:00 a.m. Eastern Time. The conference will take place at the New York Palace Hotel in New York City.
Mr. Vamvakas' presentation will be webcast live and archived for at least 90 days on the Company's website at http://www.tearlab.com under the "Webcasts" tab in the Investors section.
About TearLab Corporation
TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab® Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.
This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about TearLab. Examples of forward-looking statements in this press release include statements regarding the future potential of the TearLab Osmolarity System and the related impact on our sales. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our annual and quarterly reports on Forms 10-K and 10-Q. We do not undertake to update any forward-looking statements.
CONTACT: Stephen Kilmer (647) 872-4849 firstname.lastname@example.org